Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons.
HIV-specific CD4+ T cells may contribute to viral persistence in HIV controllers.
Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.
Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children.
Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment.
Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.
Hepatotoxicity due to a drug interaction between amodiaquine plus artesunate and efavirenz.
Rate of viral evolution and risk of losing future drug options in heavily pretreated, HIV-infected patients who continue to receive a stable, partially suppressive treatment regimen.
Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy.
